Vaccinex Announces $3 Million Award from the Alzheimer’s Drug Discovery FoundationGlobeNewsWire • 12/10/19
Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference inGlobeNewsWire • 09/27/19